We also showed that NuMA1 deletion reduced ALDH<sup>+</sup> and CD29<sup>hi</sup>CD61<sup>+</sup> breast cancer stem cells (BCSCs), indicating a role of NuMA1 in BCSCs. This evidence concerns the gene ITGB3 and breast carcinoma.